anonymous
Guest
anonymous
Guest
Everything you need to know about this competitor will go here. Rumors are also welcome.
- Phase 3 trials nearly done or complete.
- NK1 & NK3 dual receptor antagonist
- Phase 3 trials nearly done or complete.
- NK1 & NK3 dual receptor antagonist